Urologic Oncology: Seminars and Original Investigations 37 (2019) 229−262 2018 Star Reviewers for Urologic Oncology While the value of any medical journal depends upon the Sabine Brookman-May, Ph.D., M.D. quality of manuscripts received, the backbone of a journal’s LMU Munich, Dept. of Urology, Munich, Germany success is created by those who review manuscripts, iden- Clint Cary, M.D., M.P.H. tify problematic issues, make critical suggestions for Urology, Indiana University School of Medicine, Indianapolis, improvement, and assist the journal’s editors in deciding on Indiana, United States a manuscript’s disposition. This is no small task, and all too Edmund Chiong, M.B.B.S., Ph.D., F.R.C.S.Ed, F.R.C.S.I, F.A.M.S often it may feel thankless. Urology, National University Health System, Singapore, Singapore By acknowledging those reviewers whom our editors Nicholas Cost, M.D. have identified as “Star Reviewers,” Urologic Oncology Department of Surgery, Division of Urology, University of seeks to underscore the outstanding work that these Colorado School of Medicine, Aurora, CO, United States reviewers have done for the Journal over the course of this Chendil Damodaran, Ph.D. past year. We also wish to identify and thank all reviewers Urology, Univiersity of Louisville, Louisville, KY, United States for their excellent work and contributions in 2018. The Alexander Glaser, M.D. April 2019 issue of Urologic Oncology will therefore con- Department of Urology, Northwestern University, Chicago, IL, tinue its tradition of recognizing its reviewers such that all United States of our 2018 Reviewers and the Editors’ “Star Reviewers” Michael Gorin, M.D. will be formally acknowledged in the Journal with deep The James Buchanan Brady Urological Institute and Depart- ment of Urology, Johns Hopkins University School of Medicine gratitude. Maximilien Goris Gbenou, M.D. By providing your expertise, perspectives, knowledge, Urology, Centre Hospitalier de Valence, Valence, 26000, and insight, you − our reviewers − help immeasurably to Belgium enhance the value of Urologic Oncology to the readership Gabriel Haas, MD, F.A.C.S. as well as to those who contribute their work to the Journal. Medical Affairs-global, Astellas Pharma lobal Development, Inc., Northbrook, IL, United States In this, simple words cannot adequately express the grati- Marie Hupe, M.D. tude that I and my co-Editors deeply feel. Department of Urology, University Hospital Schleswig- So, simply said, a big THANK YOU from us all. Holstein Campus Luebeck, Lubeck,€ Germany The Editors and Publisher of Urologic Oncology: Zachary Klaassen, M.D. Seminars and Original Investigations, Division of Urology, Medical College of Georgia - Augusta University, Augusta, Georgia, United States Star Reviewers, 2018 Sarrah Lahorewala, United States Parth Modi, M.D., M.S. Takashige Abe, M.D./Ph.D. Urology, University of Michigan, Ann Arbor, Michigan, Department of Urology, Hokkaido University Graduate United States School of Medicine, Sapporo, Hokkaido, Japan William Parker, M.D. Safiye Aktas, M.D., Ph.D. Urology, University of Kansas Medical Center, Kansas City, Basic Oncology, Institute of Oncology, Izmir, Turkey KS, United States Aditya Bagrodia, M.D. Jose A Pedrosa, M.D. Urology, UT Southwestern, Dallas, TX, United States Urology, Department of Urology, Indiana University, Mark Ball, M.D. Indianapolis, IN, United States Urologic Oncology Branch, National Cancer Institute, Debasish Sundi, M.D. National Institutes of Health, Bethesda, MD, United States Urology, The Ohio State University, Columbus, Luca Boeri, M.D. OH Department of Urology, Fondazione IRCCS Ca’ Granda - Gang Wang, M.D, Ph.D Ospedale Maggiore Policlinico, University of Milan, Milan, Pathology, BC Cancer Vancouver Centre, Vancouver, British Italy Columbia, Canada https://doi.org/10.1016/j.urolonc.2019.02.016 230 / Urologic Oncology: Seminars and Original Investigations 37 (2019) 229−262 Stephen Williams, M.D. Stefanos Adamis, M.D., Ph.D. Urology, The University of Texas Medical Branch, Galveston, Athens, Greece TX, United States Mehrad Adibi, Urology, MD Anderson Cancer Center, Nassau Bay, All Reviewers, 2018 United States Julieta Afonso, Cory Abate-Shen Life and Health Sciences Research Institute, Columbia University, Department of Urology, University of Minho, Braga, Portugal New York, United States Neeraj Agarwal, M.D. Ronney Abaza, M.D., F.A.C.S. Internal Medicine/Medical Oncology, Huntsman Ohio State University Medical Center & Cancer Institute at the University of Utah, Salt Lake James Cancer Hospital, Columbus, OH, City, UT, United States United States Piyush Agarwal, M.D. Phillip Abbosh, M.D., Ph.D. National Cancer Institute, National Institutes of Surgical Oncology, Division of Urologic oncology, Fox Health, Bethesda, MD, United States Chase Cancer Center, Philadelphia, PA, United States Vivek Agarwala, M.D., D.M. Rania Abd-Ellatif, Ph.D. Medical Oncology, Tata Memorial Centre, Mumbai, Medical Biochemistry, Faculty of Medicine, Tanta, India Egypt Rahul Aggarwal, M.D. Aziza Abdelrahman, Ph.D., M.D. Hematology/Oncology, University of California San pathology, Faculty of medicine, Zagazig University, Francisco, San Francisco, CA, United States Zagazig, Egypt Nnenaya Agochukwu, M.D. Hamidreza Abdi, M.D. Urology, Yale New Haven Hospital/Yale School Of Urology, University of Ottawa, Ottawa, ON, Canada Medicine, Ann Arbor, MI, United States Firas Abdollah Faik, M.D. Vinita Agrawal, M.D. Vattikuti Urology Institute, Henry Ford Health Pathology, SGPGIMS, Lucknow, Uttar Pradesh, India System, Detroit, MI, United States Nariman Ahmadi, M.B.B.S., M.S., F.R.A.C.S. E Jason Abel, M.D. Urology, Chris O’brien Lifehouse, Camperdown, Houston, United States NSW, Australia E. Jason Abel, M.D. Hashim Ahmed, Ph.D., F.R.C.S. (Urol), B.M., B.Ch. Department of Urology, University of Wisconsin (Oxon), B.A. (Hons) School of Medicine and Public Health, Madison, WI, Imperial College London, Division of Surgery, Lon- United States don, United Kingdom Michael Abern, M.D. Khalil Ahmed, Department of Urology, University of Illinois at Lab Med Path, University of Minnesota and Chicago, Chicago, IL, United States MVAHCS, Minneapolis, MN, United Kingdom Aiysha Abid, Ph.D. Hanjong Ahn, M.D., Ph.D. Centre for Human Genetics and Molecular Medicine, Department of Urology, Department of Urology, Sindh Institute of Urology and Transplantation, Asan Medical Center, University of Ulsan College of Karachi, Pakistan Medicine, Seoul, Republic of Korea, Seoul, Korea, Hassan Abol-Enein, M.D., Ph.D. Republic of Urology, Urology and Nephrology Center, Mansoura, Sadia Ajaz, Ph.D. Dakahlia, Egypt University of Karachi, Karachi, Pakistan Robert Abouassaly, M.D. Hideyuki Akaza, M.D. Urologic Institute, University Hospitals Cleveland Japan Medical Center, Cleveland, United States Bulent Akdogan, M.D. Mohammad Abufaraj, M.D. Urology, Hacettepe University School of Medicine, Urology, Medical University of Vienna, Vienna, Ankara, Turkey vienna, Austria Haluk Akin, Prof.Dr. M.D. Naveen Acharya, Medical Genetics, Ege University Medical Faculty, Urology, Pgimer, Chandigarh, Chandigarh, India Izmir, Turkey Liana Adam, M.D., Ph.D. Yigit Akin, M.D. Urology, UT MD Anderson CC, Houston, Texas, Department of Urology, Izmir Katip Celebi Univer- United States sity School of Medicine, Izmir, Turkey Przemyslaw Adamczyk, M.D., Ph.D. Ashraf Al Matar, Department of general anf oncologic urology, Urology, King Fahad Specialist Hospital, Hofuf, Nicolaus Copernicus Hospital, Torun, Poland Saudi Arabia, Saudi Arabia / Urologic Oncology: Seminars and Original Investigations 37 (2019) 229−262 231 Hikmat Al-Ahmadie, M.D. Magdy Aly, Ph.D. Pathology, Memorial Sloan Kettering Cancer Center, Zoology, Faculty of Science, Beni-Suef University, New York, NY, United States Beni-Suef, Egypt Ridwan Alam, M.D., M.P.H. Ruihua An, Ph.D., M.D. The James Buchanan Brady Urological Institute, The First Affiliated Hospital of Harbin Medical Department of Urology, Johns Hopkins University University, Harbin, China School of Medicine, Baltimore, Maryland, United Umberto Anceschi, M.D., F.E.B.U. States Urology, Regina Elena National Cancer Institute, Shaheen Alanee, M.D., M.P.H., M.B.A. Rome, Italy Urology, Vattikuti Urology Institute, Detroit, Michi- Sigve Andersen, Ph.D., M.D. gan, United States Department of oncology, University Hospital Ahmad Alaqqad, M.D. of North Norway HF, Tromsø, Norway Cleveland clinic Abu Dhabi, Abu dhabi, United Arab Christopher Anderson, M.D. Emirates Urology, Columbia University Medical Center, Osamah Al-Bayati, New York, New York, United States San Antonio, Texas, United States Priscila Andrade, Peter Albers, M.D. Sao Paulo, SP, Brazil Department of Urology, Du¨sseldorf University, Du¨s- Alessandro Antonelli, md seldorf, Germany Department of Urology. ASST Spedali Civili Michele Albert, M.D. Hospital. University of Brescia. Brescia, Italy, Radiation Oncology, Bridgham and Women’s Hospi- Brescia, Italy tal, Boston, MA, United States Alberto Antunes, Peter Albertsen, M.D., M.S. Laboratory of Medical Investigation - LIM 55 - Division of Urology, MC 3955, Unversity Division of Urology, University of Sao Paulo of Connecticut Health Center, Farmington, Medical School, Sa˜o Paulo, Brazil CT, United States Ana Aparicio, M.D. Mehrdad Alemozaffar, M.D. Department of Genitourinary Medical Oncology, MD atlanta, ca, United States Anderson Cancer Center, Houston, Texas, United Fernand Algaba, M.D. States Spain Andrea Apolo, M.D. Ahmed Ragab Ali, M.D. Medical Oncology Branch, National Cancer Institute, urology,